VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CRDF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CRDFCardiff Oncology, Inc.
$0.84$65M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRDFQuarterly Cash Flow

Cardiff Oncology, Inc. (CRDF) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Cardiff Oncology, Inc. (CRDF) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

CRDF Cash Flow Statement

Quarterly statement

CRDF Cash Flow Statement

Cardiff Oncology, Inc. (CRDF) cash flow statement — 18-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-9.87M-11.77M-12.29M-5.97M-10.83M-8.33M-12.79M-10.27M-10.46M-9.23M-7.74M-7.14M-7.96M-7.13M-8.66M-9.39M-7.49M-6.7M-10.25M-7.39M
Operating CF Margin %-5774.27%-11312.5%-29970.73%-2455.56%-9028.33%-6882.64%-11737.61%-6799.34%-6336.97%-5662.58%-3775.61%-4576.28%-5643.26%-6603.7%-10432.53%-7335.94%-8049.46%-7357.14%-13850%-5556.39%
Operating CF Growth %8.86%-41.27%3.96%41.88%-3.62%9.77%-65.3%-43.82%-31.41%-29.42%10.61%23.97%-6.29%-6.53%15.51%-27.06%-36.98%-55.66%-74.18%-44.22%
Net Income-8.86M-9.23M-12.35M-7.22M-11.26M-13.94M-13.43M-11.79M-11.86M-11.78M-10.01M-9.34M-9.73M-11.15M-11.22M-8.7M-8.57M-10.44M-10.99M-9.44M
Depreciation & Amortization88K222K221K223K494K229K228K96K101K105K102K103K107K98K90K86K81K38K31K113K
Stock-Based Compensation1.34M920K1.66M1.26M1.38M1.68M1.36M1.2M1.25M1.18M1.12M909K955K1.58M1.06M1.01M1.04M1.05M1.15M990K
Deferred Taxes000000000000-10.04M000000442K
Other Non-Cash Items111K-64K-93K-158K-252K-301K-137K-158K-157K-127K-156K-205K9.73M-242K-163K-39K115K211K485K527K
Working Capital Changes-2.56M-3.61M-1.73M-77K-1.2M4M-816K378K202K1.39M1.2M1.39M1.02M2.58M1.57M-1.75M-148K2.44M-924K-20K
Change in Receivables99K2K-9K72K272K-121K368K-154K-167K-58K-105K-90K-37K515K95K-236K-99K-104K88K-215K
Change in Inventory00000000000000000000
Change in Payables-2.29M-3.48M0940K04.27M-1.04M0-1K673K1.42M0135K0203K1.35M-42K00719K
Cash from Investing3.61M12.27M3.26M10.75M10.16M-4.98M-14.58M4.51M-9.43M14.02M4.64M13.56M3.82M11.48M7.33M7.02M5.16M7.61M18.36M-8.79M
Capital Expenditures-4K-44K00-18K-26K0000-80K-8K-315K-251K-8K-75K-448K-312K-171K-107K
CapEx % of Revenue2.34%42.31%--15%21.49%----39.02%5.13%223.4%232.41%9.64%58.59%481.72%342.86%231.08%80.45%
Acquisitions000000000000315K0-7.34M-7.09M000-98K
Investments--------------------
Other Investing000-744K00-902K00000-315K07.34M7.09M43K71K098K
Cash from Financing9.13M149K105K2.55M25K03K44.19M7.43M2.06M107K0-6K00075K0014.96M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)10.15M213K105K2.55M003K44.17M7.43M2.06M107K0000075K0014.96M
Dividends Paid00000000-6K000-6K00-414K000-24K
Share Repurchases00000000000000000000
Other Financing-1.02M-64K0025K0013K6K000000414K0000
Net Change in Cash2.86M653K-8.93M7.33M-649K-13.31M-27.38M38.43M-12.46M6.84M-3M6.42M-4.14M4.35M-1.33M-2.37M-2.25M913K8.11M-1.22M
Free Cash Flow-9.88M-11.81M-12.29M-5.97M-10.85M-8.35M-12.79M-10.27M-10.46M-9.23M-7.82M-7.15M-8.27M-7.38M-8.67M-9.46M-7.93M-7.01M-10.42M-7.5M
FCF Margin %-5776.61%-11354.81%-29970.73%-2455.56%-9043.33%-6904.13%-11737.61%-6799.34%-6336.97%-5662.58%-3814.63%-4581.41%-5866.67%-6836.11%-10442.17%-7394.53%-8531.18%-7700%-14081.08%-5636.84%
FCF Growth %8.98%-41.36%3.96%41.88%-3.79%9.49%-63.61%-43.65%-26.4%-25.02%9.77%24.49%-4.26%-5.37%16.82%-26.25%-42.62%-62.92%-77.09%-44.67%
FCF per Share-0.13-0.17-0.18-0.09-0.16-0.13-0.27-0.22-0.22-0.21-0.18-0.16-0.19-0.17-0.19-0.21-0.18-0.16-0.24-0.18
FCF Conversion (FCF/Net Income)1.11x1.27x1.00x0.83x0.96x0.60x0.95x0.87x0.88x0.78x0.77x0.76x0.82x0.64x0.77x1.08x0.87x0.64x0.93x0.78x
Interest Paid00000000000000000000
Taxes Paid00000000000001K01K001K0